We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
I Agree
Email registered. Please sign in.×
Enter your contact to build trust with supplier(s)×
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Tianjin Enju Biotechnology Co.,Ltd is a leading supplier in pharmaceutical and nutrition industry in China. .Enju-Bio operates more than 2,100 products, covering the whole field of health industry, including human APIs、 veterinary APIs、 vitamins、 intermediates、 natural nutrition ingredients and pharmaceutical preparations.
With global sourcing advantages, Enju-Bio is fully capable of meeting one-stop sourcing needs of global and domestic customers. Today, Enju-Bio marketing network has spread over more than 120 countries and regions on five continents, providing professional export service for global customers, including a number of leading companies in various industries.
Over the last 15 years, Enju Biotechnology has been involved in manufacturing area as well as export business. We concentrate on the global marketing analysis of products, sales and customized manufacturing and establish our own R&D centers for developing new products，with the aim to constantly ensure high quality products and professional service for our customers.
Now our strong API like Steroids Pimobendan, Trilostane, Fluralaner, Afoxolaner, Tacrolimus, Ciclosporin, Alpha lipoic acid are widely exported to European, American, Latam and Asian countries.
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
